Multidisciplinary Care in High-Risk Prostate Cancer Is the New Standard of Care

J Clin Oncol. 2019 May 10;37(14):1143-1147. doi: 10.1200/JCO.19.00298. Epub 2019 Mar 22.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Docetaxel*
  • Humans
  • Male
  • Medical Oncology
  • Prostatic Neoplasms*
  • Standard of Care

Substances

  • Docetaxel